PARLIAMENTARY WRITTEN QUESTION
(27 February 2025)

To ask the Secretary of State for Health and Social Care, what steps he is taking to help improve the level of participation in clinical trials for (a) leukaemia patients diagnosed with acute subtypes and (b) all leukaemia patients.

Asked by:
Pippa Heylings (Liberal Democrat)

The Department is committed to maximising our potential to lead the world in clinical trials and ensuring that clinical trials are more accessible.

The Department funded National Institute of Health and Care Research (NIHR) funds research and research infrastructure, which supports patients and the public to participate in high-quality research, including clinical research on leukaemia. NIHR research expenditure for all cancers was £133 million in 2023/24, reflecting its high priority. These investments are pivotal to informing efforts to improve cancer prevention, treatment, and outcomes, including leukaemia research.

The NIHR provides an online service called Be Part of Research which promotes participation in health and social care research, including research into leukaemia and the acute subtypes of leukaemia, by allowing users to search for relevant studies and register their interest. This makes it easier for people to find and take part in health and care research that is relevant to them.

Answered by:
()